Evidence map›Paper›PMID 25648832›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2015

Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high-fat diet in mice.

William D Stuart, Nicholas E Brown, Andrew M Paluch, Susan E Waltz

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Transcriptomics and metabonomics analyses of maternal DEHP exposure on male offspring.Environmental science and pollution research international · 2018
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

William D StuartDepartment of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio; and.
Nicholas E BrownDepartment of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio; and.
Andrew M PaluchDepartment of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio; and.
Susan E WaltzDepartment of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio; and Department of Research, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio susan.waltz@uc.edu.
University of Cincinnati Medical Center · USVeterans Health Administration · US

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI LEE ARMISTEAD DENSON · 2007 to 2026
$24.4M
LIPID, LIPOPROTEIN, AND GLUCOSE METABOLISM COREU24DK059630 · NIDDK · UNIVERSITY OF CINCINNATI · PI TSO, PATRICK · 2001 to 2015
$12.9M
Training Program in Cancer TherapeuticsT32CA117846 · NCI · UNIVERSITY OF CINCINNATI · PI PRICE, CAROLYN M, TAKIAR, VINITA · 2006 to 2022
$6.5M
Hepatocyte Growth Factor-like Protein ReceptorR01DK073552 · NIDDK · UNIVERSITY OF CINCINNATI · PI WALTZ, SUSAN E · 2005 to 2009
$1.5M
The Ron Receptor/Chemokine Axis in Prostate CancerR01CA125379 · NCI · UNIVERSITY OF CINCINNATI · PI WALTZ, SUSAN E · 2008 to 2012
$1.3M
Lineage-Specific Roles for the Ron Receptor in Prostate CancerF31CA165767 · NCI · UNIVERSITY OF CINCINNATI · PI PALUCH, ANDREW · 2012 to 2015
$118k
Ron Receptor Tyrosine Kinase Signaling in Breast CancerI01BX000803 · VA · CINCINNATI VA MEDICAL CENTER RESEARCH · PI WALTZ, SUSAN E · 2011 to 2025
–
BLRD VA I01 BX000803NCI NIH HHS F31 CA165767NCI NIH HHS F31-CA-165767NCI NIH HHS R01 CA125379NCI NIH HHS R01-CA-125379NCI NIH HHS T32 CA117846NCI NIH HHS T32-CA-117846NIDDK NIH HHS P30 DK078392NIDDK NIH HHS P30-DK-078392NIDDK NIH HHS R01 DK073552NIDDK NIH HHS R01-DK-73552NIDDK NIH HHS U24 DK059630NIDDK NIH HHS U24-DK-059630
6 · The paper itself

Abstract

The Ron receptor tyrosine kinase is a heterodimeric, membrane-spanning glycoprotein that participates in divergent processes, including proliferation, motility, and modulation of inflammatory responses. We observed male C57BL/6 mice with a global deletion of the Ron tyrosine kinase signaling domain (TK(-/-)) to be leaner compared with control (TK(+/+)) mice under a standard diet. When fed a high-fat diet (HFD), TK(-/-) mice gained 50% less weight and were more insulin sensitive and glucose tolerant than controls. Livers from HFD TK(-/-) mice were considerably less steatotic and weighed significantly less than TK(+/+) livers. Serum cytokine levels of HFD TK(-/-) mice were also significantly altered compared with TK(+/+) mice. Fewer and smaller adipocytes were present in the TK(-/-) mice on both control and HFD and were accompanied by diminished adiponectin and peroxisome proliferator-activated receptor-γ expression. In vitro adipogenesis experiments suggested reduced differentiation in TK(-/-) embryonic fibroblasts (MEFs) that was rescued by Ron reconstitution. Likewise, signal transducer and activator of transcription (STAT)-3 phosphorylation was diminished in TK(-/-) MEFs but was increased after Ron reconstitution. The adipogenic inhibitors, preadipocyte factor 1 and Sox9, were elevated in TK(-/-) MEFs and increased in both groups after STAT3 silencing. In total, these studies document a previously unknown function for the Ron receptor in mediating HFD-induced obesity and metabolic dysregulation.

Indexed as

Diet, High-FatAnimalsCatalytic DomainCells, CulturedDiabetes MellitusEmbryo, MammalianFatty LiverGene DeletionMaleMiceMice, Inbred C57BLMice, KnockoutObesityProtein-Tyrosine KinasesReceptor Protein-Tyrosine KinasesSignal TransductionProtein-Tyrosine KinasesReceptor Protein-Tyrosine KinasesRON proteinreceptor tyrosine kinaseRon tyrosine kinasesignal transducer and activator of transcription 3

Identifiers

PMID25648832
PMCPMC4385874
OpenAlexW1999893011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.